Jama-Journal of the American Medical Association最新文献

筛选
英文 中文
Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease. 泽拉西兰治疗动脉粥样硬化性心血管疾病。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0031
Yumei Wu, Jiahao Meng, Shuguang Gao
{"title":"Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease.","authors":"Yumei Wu, Jiahao Meng, Shuguang Gao","doi":"10.1001/jama.2025.0031","DOIUrl":"10.1001/jama.2025.0031","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1456-1457"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Immoderate Publicity of Science. 科学的过度宣传。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2024.18802
{"title":"The Immoderate Publicity of Science.","authors":"","doi":"10.1001/jama.2024.18802","DOIUrl":"10.1001/jama.2024.18802","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1462"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US Hospital Bed Shortage Looms as Occupancy Rates Climb. 入住率攀升,美国医院床位短缺迫在眉睫。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2574
Samantha Anderer
{"title":"US Hospital Bed Shortage Looms as Occupancy Rates Climb.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2574","DOIUrl":"10.1001/jama.2025.2574","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1386"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gap Years-Reply. 差距Years-Reply。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0168
Richard M Schwartzstein, Sammer Marzouk
{"title":"Gap Years-Reply.","authors":"Richard M Schwartzstein, Sammer Marzouk","doi":"10.1001/jama.2025.0168","DOIUrl":"10.1001/jama.2025.0168","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1459-1460"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Travel Time to Obtain Surgical Care for Rural Patients. 农村患者获得外科治疗的旅行时间趋势。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0447
Cody Lendon Mullens, Reagan A Collins, Nicholas Kunnath, Janice C Probst, Andrew M Ibrahim
{"title":"Trends in Travel Time to Obtain Surgical Care for Rural Patients.","authors":"Cody Lendon Mullens, Reagan A Collins, Nicholas Kunnath, Janice C Probst, Andrew M Ibrahim","doi":"10.1001/jama.2025.0447","DOIUrl":"10.1001/jama.2025.0447","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1453-1455"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11822571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia. 在有和没有初始病毒血症的人群中使用长效抗逆转录病毒治疗抑制HIV病毒。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0109
Matthew A Spinelli, Megan J Heise, Nathanial Gistand, Chesa Cox, Janet Grochowski, Jon Oskarsson, David V Glidden, Monica Gandhi
{"title":"HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.","authors":"Matthew A Spinelli, Megan J Heise, Nathanial Gistand, Chesa Cox, Janet Grochowski, Jon Oskarsson, David V Glidden, Monica Gandhi","doi":"10.1001/jama.2025.0109","DOIUrl":"10.1001/jama.2025.0109","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1451-1453"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Data Errors. 数据错误。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.4205
{"title":"Data Errors.","authors":"","doi":"10.1001/jama.2025.4205","DOIUrl":"10.1001/jama.2025.4205","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1460"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11950972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply. Zerlasiran治疗动脉粥样硬化性心血管疾病
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0034
Steven E Nissen
{"title":"Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply.","authors":"Steven E Nissen","doi":"10.1001/jama.2025.0034","DOIUrl":"10.1001/jama.2025.0034","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1457-1458"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial. 高剂量维生素D治疗多发性硬化症临床孤立综合征:D- lay MS随机临床试验
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.1604
Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, Nathalie Derache, Emmanuelle Le Page, Elisabeth Maillart, Caroline Froment-Tilikete, Giovanni Castelnovo, Olivier Casez, Marc Coustans, Anne-Marie Guennoc, Olivier Heinzlef, Laurent Magy, Chantal Nifle, Xavier Ayrignac, Agnès Fromont, Nicolas Gaillard, Nathalie Caucheteux, Ivania Patry, Jérôme De Sèze, Romain Deschamps, Pierre Clavelou, Damien Biotti, Gilles Edan, William Camu, Hanane Agherbi, Dimitri Renard, Christophe Demattei, Pascale Fabbro-Peray, Thibault Mura, Manon Rival
{"title":"High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.","authors":"Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, Nathalie Derache, Emmanuelle Le Page, Elisabeth Maillart, Caroline Froment-Tilikete, Giovanni Castelnovo, Olivier Casez, Marc Coustans, Anne-Marie Guennoc, Olivier Heinzlef, Laurent Magy, Chantal Nifle, Xavier Ayrignac, Agnès Fromont, Nicolas Gaillard, Nathalie Caucheteux, Ivania Patry, Jérôme De Sèze, Romain Deschamps, Pierre Clavelou, Damien Biotti, Gilles Edan, William Camu, Hanane Agherbi, Dimitri Renard, Christophe Demattei, Pascale Fabbro-Peray, Thibault Mura, Manon Rival","doi":"10.1001/jama.2025.1604","DOIUrl":"10.1001/jama.2025.1604","url":null,"abstract":"<p><strong>Importance: </strong>Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting.</p><p><strong>Objective: </strong>To evaluate the efficacy of high-dose cholecalciferol as monotherapy in reducing disease activity in patients with clinically isolated syndrome (CIS) typical for MS.</p><p><strong>Design, setting, and participants: </strong>The D-Lay MS trial was a parallel, double-blind, randomized placebo-controlled clinical trial in 36 MS centers in France. Patients were enrolled from July 2013 to December 2020 (final follow-up on January 18, 2023). Untreated patients with CIS aged 18 to 55 years with CIS duration less than 90 days, serum vitamin D concentration less than 100 nmol/L, and diagnostic magnetic resonance imaging (MRI) meeting 2010 criteria for dissemination in space or 2 or more lesions and presence of oligoclonal bands were recruited.</p><p><strong>Intervention: </strong>Patients were randomized 1:1 to receive oral cholecalciferol 100 000 IU (n = 163) or placebo (n = 153) every 2 weeks for 24 months.</p><p><strong>Main outcomes and measures: </strong>The primary outcome measure was disease activity, defined as occurrence of a relapse and/or MRI activity (new and/or contrast-enhancing lesions) over 24 months of follow-up, also analyzed as separate secondary outcomes.</p><p><strong>Results: </strong>Of the 316 participants enrolled and randomized (median [IQR] age, 34 [28-42] years; 70% women), the primary analysis included 303 patients (95.9%) who took at least 1 dose of the study drug and 288 (91.1%) ultimately completed the 24-month trial. Disease activity was observed in 94 patients (60.3%) in the vitamin D group and 109 patients (74.1%) in the placebo group (hazard ratio [HR], 0.66 [95% CI, 0.50-0.87]; P = .004), and median time to disease activity was longer in the vitamin D group (432 vs 224 days; log-rank P = .003). All 3 secondary MRI outcomes reported significant differences favoring the vitamin D group vs the placebo group: MRI activity (89 patients [57.1%] vs 96 patients [65.3%]; HR, 0.71 [95% CI, 0.53-0.95]; P = .02), new lesions (72 patients [46.2%] vs 87 patients [59.2%]; HR, 0.61 [95% CI, 0.44-0.84]; P = .003), and contrast-enhancing lesions (29 patients [18.6%] vs 50 patients [34.0%]; HR, 0.47 [95% CI, 0.30-0.75]; P = .001). All 10 secondary clinical outcomes showed no significant difference, including relapse, which occurred in 28 patients (17.9%) in the vitamin D group vs 32 (21.8%) in the placebo group (HR, 0.69 [95% CI, 0.42-1.16]; P = .16). Results were similar in a subset of 247 patients meeting updated 2017 diagnostic criteria for relapsing-remitting MS at treatment initiation. Severe adverse events occurred in 17 patients in the vitamin D group and 13 in the placebo group, none of which were related to cholecalciferol.</p><p><strong>Conclusions and relevance: </strong>Oral cholecalc","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1413-1422"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11894546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPV Vaccine Cuts Cervical Precancer Incidence, but Rural Access Gaps Remain. HPV 疫苗降低了宫颈癌前病变的发病率,但农村地区的接种率仍有差距。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2573
Samantha Anderer
{"title":"HPV Vaccine Cuts Cervical Precancer Incidence, but Rural Access Gaps Remain.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2573","DOIUrl":"10.1001/jama.2025.2573","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1385-1386"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信